Nuclera, a biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, has completed a £57 million financing round. The fundraise was led by Elevage Medical Technologies, backed by Patient Square Capital, and joined by British Patient Capital, the largest domestic investor in UK venture and venture growth opportunities, Cambridge Innovation Capital, … Continue reading Nuclera closes £57m Series C financing